Nexalin Technology, Inc. is projected to rise to $0.7919 by 2027, a +42% move from its current price of $0.559. NXL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.5183 | $0.5587 | $0.6024 | -0.05% |
| May 30 | $0.5021 | $0.5585 | $0.6211 | -0.09% |
| May 31 | $0.4901 | $0.5582 | $0.6358 | -0.14% |
| Jun 1 | $0.4801 | $0.558 | $0.6485 | -0.19% |
| Jun 2 | $0.4714 | $0.5577 | $0.6598 | -0.23% |
| Jun 3 | $0.4637 | $0.5574 | $0.6701 | -0.28% |
| Jun 4 | $0.4567 | $0.5572 | $0.6798 | -0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4567 | $0.5572 | $0.6798 | -0.33% |
| Week 2 | $0.4192 | $0.5553 | $0.7357 | -0.66% |
| Week 3 | $0.3922 | $0.5535 | $0.7812 | -0.98% |
| Week 4 | $0.3706 | $0.5517 | $0.8212 | -1.31% |
| Week 5 | $0.3525 | $0.5499 | $0.8579 | -1.63% |
| Week 6 | $0.3367 | $0.5481 | $0.8921 | -1.95% |
| Week 7 | $0.3228 | $0.5463 | $0.9246 | -2.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nexalin Technology, Inc. is a medical device company that designs and develops neurostimulation products for the treatment of mental health issues in the United States and China. It offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Nexalin Technology, Inc. is headquartered in Houston, Texas.
Nexalin Technology, Inc. trades under the ticker NXL and is currently priced at $0.559, with a market capitalization of $12.04M and a market rank of 5045. The stock sits in the healthcare sector as a small-cap clinical device company focused on neurostimulation for mental health conditions.
A major floor 56.8% below — a decisive break under it would weaken the trend.
The nearest floor, 42.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 28.4% above — clearing it would confirm fresh momentum.
Key NXL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NXL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4302 | Buy | $0.4542 | Buy |
| MA 10 | $0.382 | Buy | $0.4114 | Buy |
| MA 20 | $0.3684 | Buy | $0.3918 | Buy |
| MA 50 | $0.3906 | Buy | $0.4116 | Buy |
| MA 100 | $0.4699 | Buy | $0.5118 | Buy |
| MA 200 | $0.7506 | Sell | $0.7432 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.97 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 347.56 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 58.81 | Buy |
| Bollinger %B (20,2) | 1.36 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.38 | Sell |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 80.63 | Sell |
| Momentum (10) | 0.22 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 0.49 | Buy |
| ADX (14) | 21.61 | Buy |
| ATR (14) | 0.03 | Info |
The stock shows a neutral technical stance with RSI(14) at 70, and the moving averages nearby at $0.3906 (SMA50) and $0.7506 (SMA200). The current setup places price action within defined technical levels, giving a framework for near-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.321 | $0.559 | $0.9259 | 0% | Neutral | |
| $0.5699 | $0.7919 | $1.19 | +42% | Bullish | |
| $0.509 | $0.7506 | $1.20 | +34% | Bullish | |
| $0.5141 | $0.7981 | $1.34 | +43% | Bullish | |
| $0.4117 | $0.6697 | $1.17 | +20% | Neutral | |
| $0.4057 | $0.6895 | $1.24 | +23% | Bullish | |
| $0.4806 | $0.8518 | $1.58 | +52% | Bullish | |
| $0.5247 | $0.9682 | $1.85 | +73% | Bullish | |
| $0.604 | $1.16 | $2.27 | +107% | Bullish | |
| $0.5799 | $1.16 | $2.32 | +107% | Bullish | |
| $0.7236 | $1.61 | $3.54 | +188% | Bullish | |
| $1.00 | $2.23 | $5.13 | +299% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.321 | $0.559 | $0.6678 | +0.00% |
| June 2026 | $0.4597 | $0.5513 | $0.6851 | -1.37% |
| July 2026 | $0.4391 | $0.5356 | $0.6826 | -2.86% |
| August 2026 | $0.4676 | $0.578 | $0.7509 | +7.92% |
| September 2026 | $0.4816 | $0.6019 | $0.7943 | +4.14% |
| October 2026 | $0.4622 | $0.5836 | $0.781 | -3.04% |
| November 2026 | $0.4793 | $0.6106 | $0.8271 | +4.64% |
| December 2026 | $0.5258 | $0.6758 | $0.9259 | +10.67% |
Click any year to see its month-by-month NXL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NXL to range from $0.321 to $0.9259 through 2026. The $0.559 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The NXL price prediction for 2027 points to an average of $0.7919 (low $0.5699, high $1.19) — a potential gain of +42% on today's $0.559. Momentum favours further upside here.
In 2028, NXL is projected to trade between $0.509 and $1.20, averaging $0.7506 — a potential gain of +34% from today's $0.559. That is -5% versus the projected 2027 average. Buyers look set to stay in control over this stretch.
Nexalin Technology, Inc.'s 2029 outlook centres on $0.7981, within a $0.5141 to $1.34 range. That is up +6% on the projected 2028 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2030, NXL could reach as high as $1.17, with a base case around $0.6697 and support toward $0.4117 — roughly +20% from $0.559. A consolidation phase looks the most probable path here.
Expect NXL to range from $0.4057 to $1.24 through 2031. The $0.6895 average target implies a +23% move from current prices. That is up +3% on the projected 2030 average. Momentum favours further upside here.
The NXL price prediction for 2032 points to an average of $0.8518 (low $0.4806, high $1.58) — a potential gain of +52% on today's $0.559. Buyers look set to stay in control over this stretch.
In 2033, NXL is projected to trade between $0.5247 and $1.85, averaging $0.9682 — a potential gain of +73% from today's $0.559. That is up +14% on the projected 2032 average. Momentum favours further upside here.
Nexalin Technology, Inc.'s 2034 outlook centres on $1.16, within a $0.604 to $2.27 range. That is up +20% on the projected 2033 average. That marks a +107% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, NXL could reach as high as $2.32, with a base case around $1.16 and support toward $0.5799 — roughly +107% from $0.559. Momentum favours further upside here.
Expect NXL to range from $0.7236 to $3.54 through 2040. The $1.61 average target implies a +188% move from current prices. That is up +39% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The NXL price prediction for 2050 points to an average of $2.23 (low $1.00, high $5.13) — a potential gain of +299% on today's $0.559. Momentum favours further upside here.
Investing $1,000 in NXL today (≈ 1,788.908766 NXL) could be worth
$3,993.27
+$2,993.27 (+299%) by 2050 · US Dollar
Based on the average projected NXL price of $2.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NXLwould be worth at today's price.
$1,000 invested in NXL on May 27, 2025 (≈ 826.446255 NXL) would be worth
$461.98
-$538.02 (-53.8%) today · 0.46× · US Dollar
Based on a NXL entry price of $1.21 vs. today's $0.559.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.335 | $1,668.66 | +66.9% |
| 1 month ago | $0.405 | $1,380.25 | +38.0% |
| 3 months ago | $0.522 | $1,070.88 | +7.1% |
| 6 months ago | $1.08 | $517.59 | -48.2% |
| 1 year ago | $1.21 | $461.98 | -53.8% |
| All time (3.7y) ago | $2.25 | $248.44 | -75.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NXL forecast.
Our base-case forecast reaches $1.10 around 2034.
Implied market cap at $1.10: $23.69M
The multi-year forecast outlines a path of gradual upside with notable bullish momentum in several years. The 2027 average price is $0.7919 with a 41.7% ROI and a bullish sentiment, followed by 2028 at $0.7506 (34.3% ROI) and 2029 at $0.7981 (42.8% ROI). By 2030 the average is $0.6697 with a 19.8% ROI and neutral sentiment, then continuing with higher potential in 2032–2035, 2040, and 2050, culminating in a 2050 average of $2.23 and a 299.3% ROI.
The forecast also shows high upside in later years (e.g., 2040 avg $1.61, 187.7% ROI; 2050 avg $2.23, 299.3% ROI), with bullish sentiment in those periods. These figures are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The 2030 forecast shows min $0.4117, avg $0.6697, max $1.17 with ROI 19.8% and sentiment NEUTRAL.
The forecast includes bullish years such as 2027 (avg $0.7919, ROI 41.7%), 2028 (avg $0.7506, ROI 34.3%), and 2029 (avg $0.7981, ROI 42.8%), but 2026 is neutral and outcomes remain uncertain.
Yes. The max forecast shows $2.27 in 2034 and $2.32 in 2035, with higher maxs of $3.54 in 2040 and $5.13 in 2050.
RSI(14) is 70, with SMA50 at $0.3906 and SMA200 at $0.7506. The 30-day range is $0.3406 to $0.9175, with support at $0.321 and resistance at $0.559.
The current price is $0.559, the market cap is $12.04M, and the rank is 5045.
Nexalin Technology, Inc. Community Discussion
0Share your Nexalin Technology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.